Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Anti-cancer nuclear hormone receptor-targeting compounds

US Patent 11952349 · Granted Apr 9, 2024

Estimated economic value: $13,074,000

Assignee

Inventors

View full patent text on Google Patents →